The historical rank and industry rank for Chiome Bioscience's OCF Margin % or its related term are showing as below:
TSE:4583'
s OCF Margin % Range Over the Past 10 Years
Min: -793.38 Med: -235.83 Max: -128.16
Current: -359.64
During the past 13 years, the highest OCF Margin % of Chiome Bioscience was -128.16%. The lowest was -793.38%. And the median was -235.83%.
TSE:4583's OCF Margin % is ranked worse than 68.75% of 960
companies
in the Biotechnology industry
Industry Median: -68.59
vs TSE:4583: -359.64
Chiome Bioscience OCF Margin % Related Terms
Chiome Bioscience OCF Margin % Historical Data
* Premium members only.
The historical data trend for Chiome Bioscience's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4583 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, Chiome Bioscience's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chiome Bioscience OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Chiome Bioscience's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Chiome Bioscience's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chiome Bioscience (TSE:4583) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Chiome Bioscience and its competitors. According to the industry distribution chart, Chiome Bioscience ranks #660 out of 960 companies in the Biotechnology industry, placing it in the top 68.7%.
Is Chiome Bioscience's OCF Margin % too high?
Chiome Bioscience's current OCF Margin % is 0.00%. Based on the distribution chart, Chiome Bioscience ranks #660 out of 960 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Chiome Bioscience has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chiome Bioscience's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Chiome Bioscience ranks #660 out of 960 companies for OCF Margin %. This places Chiome Bioscience in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Chiome Bioscience and its competitors. Chiome Bioscience's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chiome Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Chiome Bioscience (TSE:4583) is currently considered Modestly Undervalued. The stock's GF Value™ is 円82.68, compared to a current price of 円66.00 — trading 20.2% below its estimated fair value. The current OCF Margin % is 0.00%. Chiome Bioscience's overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Chiome Bioscience (TSE:4583), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chiome Bioscience (TSE:4583) Overvalued in 2026?
Based on GuruFocus' analysis, Chiome Bioscience stock appears to be undervalued.
The current stock price of 円66.00 is trading 20.2% below its estimated GF Value™ of 円82.68.
GuruFocus considers Chiome Bioscience to be Modestly Undervalued.
Key valuation signals for TSE:4583:
OCF Margin %: 0.00%
GF Value™: 円82.68 vs. price of 円66.00 (20.2% below fair value)
No single metric tells the full story. See the TSE:4583 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chiome Bioscience Inc is engaged in the discovery and development of antibody drugs, focusing on early-stage research and initial clinical trials. The company operates through two reportable segments: the Drug Discovery segment and the Drug Discovery Support segment. The Drug Discovery segment conducts research on antibody creation for diseases with high unmet medical needs and aims to generate revenue through licensing agreements, upfront payments, milestone payments, and royalties. The Drug Discovery Support segment provides services such as antibody production and related support using proprietary antibody technologies, catering to pharmaceutical and diagnostic companies as well as academic institutions.
50GF Score
Get the complete analysis for TSE:4583
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4583 has been successfully added to your 
